Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma.
David G CoffeyQian V WuAndrea M H TowlertonSharon OrnelasAlicia J MoralesYuexin XuDamian J GreenEdus H WarrenPublished in: Blood cancer journal (2019)